Mylan’s stock has fallen by more than three-fourths in the last 4 years. The company announced a merger with UpJohn this year, and the market received it well. Investors need to make decisions around ...

Mylan’s $12 billion takeover of Pfizer’s Upjohn unit has been cleared by the US authorities, but on the condition that the two companies divest various generic drug products. The Federal Trade ...

Finding the perfect name is no easy task for a new company, particularly in the exotic world of biopharma monikers. Mylan and Pfizer's Upjohn, working to close their generics megamerger, believe they ...

Their merger isn't official yet, but a new logo is ready to go. Mylan and Pfizer's Upjohn unit unveiled new branding for the to-be-combined company, dubbed Viatris, on Thursday with a tri-color scheme ...

The early reaction to the pairing of generic drug maker Mylan Laboratories and Pfizer’s generics unit, Upjohn — officially announced Monday — is that it’s great for Mylan but maybe not so amazing for ...

Mylan NV and Pfizer on Tuesday said the name of the new company to be formed after the merger of Mylan and Pfizer division Upjohn will be Viatris. A note issued by Mylan says the name is derived from ...

PITTSBURGH (KDKA/AP) -- Pfizer is buying Mylan in an all-stock deal and combining the $10 billion generic pharmaceutical company with its own off-patent branded and generic business. The Pfizer ...